Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00997126 · ClinicalTrials.gov registry record · Phase 4

Propofol Versus Alfentanil Versus Nitrous Oxide for Moderate Procedural Sedation

A Phase 4 study of Sedation, sponsored by Hennepin Healthcare Research Institute.

Completed
Registry status
Phase 4
Development phase
126
Enrollment target
1
Study location

NCT00997126: Completed Phase 4 study of Sedation, sponsored by Hennepin Healthcare Research Institute.

NCT00997126 is a Phase 4 study of Sedation that has completed, run by Hennepin Healthcare Research Institute. The registered enrollment target is 126 participants, below the 100,175-participant average among 12 other Sedation trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00997126, a Phase 4 study of Sedation, has completed, sponsored by Hennepin Healthcare Research Institute.

COMPLETED
Registry status
Phase 4
Development phase
126 participants
Enrollment target
1
Study location

Study Summary

This is a clinical trial of propofol and alfentanil as agents for moderated procedural sedation in patients undergoing sedation in the emergency department (ED).

Conditions Studied

Interventions

  • DRUG Propofol
  • DRUG Alfentanil

Study Locations (1)

Minnesota

  • Hennepin County Medical Center - Minneapolis

Trial Details

FieldValue
Enrollment Target 126 participants
Start Date 2009-10
Est. Completion 2015-04
Phase Phase 4

What the finished NCT00997126 record still lists

NCT00997126 is an interventional study that assigns participants to a tested intervention. The registered 126 participants enrollment target is mid-sized for trials with a published cap, below the 100,175-participant average among 12 other Sedation trials with a reported enrollment target (100% lower).

The record links to 1 condition, with Sedation appearing as the primary indexed condition, and to 2 interventions - of which Propofol is the first listed.

NCT00997126 reports a single indexed study location in Minnesota.

Frequently Asked Questions

What is clinical trial NCT00997126 about?

NCT00997126 is a clinical study titled "Propofol Versus Alfentanil Versus Nitrous Oxide for Moderate Procedural Sedation". This is a clinical trial of propofol and alfentanil as agents for moderated procedural sedation in patients undergoing sedation in the emergency department (ED).

What is the current status of trial NCT00997126?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 126 participants. The study started on 2009-10. Estimated completion is 2015-04.

What conditions does trial NCT00997126 study?

This clinical trial studies the following conditions: Sedation.

What interventions are being tested in trial NCT00997126?

The interventions under investigation include: Propofol (DRUG), Alfentanil (DRUG).

Who is sponsoring clinical trial NCT00997126?

This trial is sponsored by Hennepin Healthcare Research Institute, which has 63 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00997126 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sedation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00997126's enrollment target sits among peer trials

126 7th of 12 higher than 6 of 12 other Sedation trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Sedation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01873131 · 126 participants · NA

    A Clinical Trial of Pulsed-dye Laser Versus Timolol Topical Solution Versus Observation on the Growth of Hemangioma in Newborn

  • NCT02621645 · 126 participants · Phase 4

    TRAP Intervention STudy: Early Versus Late Intervention for Twin Reversed Arterial Perfusion Sequence

  • NCT03838107 · 126 participants

    Markers of Trajectory in Pediatric CRPS

  • NCT03906422 · 126 participants · NA

    Comparison of Patient-reported Pain After Initial Archwire Placement

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00997126, the US trial registry maintained by the National Library of Medicine. NCT00997126 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.